Skip to main content
Skip to navigation
Research Exchange
Living Lab
Discovery Lab
Donate
Correspondence on “Elenagen, a p62/SQSTM1-encoding plasmid, improves overall survival in patients with platinum-resistant ovarian cancer: a phase II trial” by Krasny et al
David Viveros-Carreño
· 2026-02-02
Links
DOI
PubMed
Journal
International Journal of Gynecological Cancer
Institutions
Instituto Nacional De Cancerologa Httpsrororg02hdnbe80
Authors
David Viveros-Carreño